Total: 6 |
|
PMID (PMCID) | ||
---|---|---|
30733892 |
OTHER | |
Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma. | ||
O'Connor-Byrne N, Glavey S, Tudor R, Murphy P, Thompson CJ, Quinn J. Exp Hematol Oncol. 2019;8:4. |
||
The development of hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) is well recognised in multiple myeloma (MM). | ||
22073499 |
FEMALE | Middle Aged |
Syndrome of inappropriate antidiuretic hormone due to multiple myeloma. | ||
Abraham A, Shafi F, Iqbal M, Kollipara R, Rouf E. Mo Med. 2011;108(5):377-9. |
||
Although there is a plethora of literature reporting multiple myeloma induced spurious hyponatremia, our review revealed only one case report, in 1983, describing multiple myeloma induced SIADH. | ||
22073499 |
FEMALE | Middle Aged |
Syndrome of inappropriate antidiuretic hormone due to multiple myeloma. | ||
Abraham A, Shafi F, Iqbal M, Kollipara R, Rouf E. Mo Med. 2011;108(5):377-9. |
||
Although there is a plethora of literature reporting multiple myeloma induced spurious hyponatremia, our review revealed only one case report, in 1983, describing multiple myeloma induced SIADH. | ||
6823611 |
FEMALE | |
Multiple myeloma and syndrome of inappropriate secretion of antidiuretic hormone. | ||
Nanji AA. South Med J. 1983;76(2):270. |
||
I have described a patient with multiple myeloma who had hyponatremia probably secondary to SIADH. | ||
645438 |
MIXED_SAMPLE | |
Extreme hyponatremia in patients with myelomatosis: an effect of cationic paraproteins. | ||
Bloth B, Christensson T, Mellstedt H. Acta Med Scand. 1978;203(4):273-5. |
||
Extreme hyponatremia in patients with myelomatosis: an effect of cationic paraproteins. | ||
10101 |
MALE | Adult |
Negative anion gap in a young adult with multiple myeloma. | ||
Gumprecht T, O'Connor DT, Rearden A, Wolf PL. Clin Chem. 1976;22(11):1920-1. |
||
A young patient with multiple myeloma was found to have a negative anion gap, with marked asymptomatic hyponatremia. |